Initial Management of Polyarthalgia with Skin Rash

Immediate Critical Exclusions

The American College of Physicians and the Centers for Disease Control and Prevention recommend immediate assessment to exclude life-threatening conditions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS syndrome, followed by systematic evaluation of rash severity, joint involvement pattern, and consideration of infectious, drug-induced, and inflammatory rheumatic etiologies in patients with polyarthalgia and skin rash 1, 2, 3
Stevens-Johnson syndrome and toxic epidermal necrolysis present with mucosal involvement, blister formation, and skin detachment, requiring immediate drug discontinuation and hospitalization, as recommended by the American Academy of Dermatology 2, 3, 1
DRESS syndrome manifests with fever, eosinophilia, hematological abnormalities, and multi-organ involvement, typically appearing weeks after drug initiation, according to the American College of Clinical Pharmacy 2, 3

The American Academy of Family Physicians recommends documenting the temporal relationship between rash onset and any new medications, especially within the first 2-3 weeks, with particular attention to NNRTIs, abacavir, and amprenavir, which commonly cause rash 2, 3, 1
A complete medication review, including over-the-counter drugs and supplements, is essential, as recommended by the National Institute of Arthritis and Musculoskeletal and Skin Diseases 1

The American College of Rheumatology recommends calculating body surface area involvement to determine severity grading, and examining all mucous membranes for involvement suggesting SJS/TEN 5, 1
Evaluating joint pattern, including polyarticular versus oligoarticular, presence of dactylitis, and enthesitis, is crucial, according to the European League Against Rheumatism 6

The American Society of Clinical Oncology recommends ordering a complete blood count to assess for eosinophilia, leukocytosis, or thrombocytopenia, and a comprehensive metabolic panel for baseline organ function 4, 1, 5
Arboviral serologies, such as dengue PCR and chikungunya PCR, should be considered in travelers, as recommended by the Centers for Disease Control and Prevention 4

The National Comprehensive Cancer Network recommends continuing monitoring without drug discontinuation if non-severe, and applying topical emollients and mild-to-moderate potency topical corticosteroids for Grade 1 rash 5, 1
For Grade 2 rash, considering holding suspected causative medication and monitoring weekly, and applying medium-to-high potency topical corticosteroids, is recommended by the American Academy of Dermatology 5, 1
Immediate hospitalization with permanent discontinuation of all suspected agents is required for Grade 4 rash, according to the American College of Emergency Physicians 5, 1

The American Academy of Dermatology recommends never using prophylactic corticosteroids when initiating drugs known to cause rash, as this increases rash incidence 2, 3, 1
Avoiding sedating antihistamines in elderly patients due to fall and cognitive impairment risk is crucial, according to the American Geriatrics Society 1

The American Academy of Dermatology recommends referring urgently if autoimmune skin disease is suspected based on clinical pattern, or if there is no response to initial treatment after 2 weeks 5, 1

The American College of Physicians recommends weekly assessment for Grade 2 rash until improvement to Grade 1, and immediate consultation if flare-up or systemic symptoms develop 5, 7
Reassessing joint involvement at 4 weeks to determine if treatment target is achieved is essential, according to the European League Against Rheumatism 6